Boston Scientific rises after Q1 results beat, FY forecast raise

Shares of medical device maker Boston Scientific BSX.N rise 4.4% to $99.24 premarket

Co reports Q1 adjusted profit of 75 cents per share, topping analysts' estimates of 67 cents per share, according to estimates compiled by LSEG

Q1 revenue came in at $4.66 billion vs estimates of $4.57 billion

BSX raises 2025 adjusted EPS forecast to $2.87-$2.94 from $2.80-$2.87 per share

Analysts were expecting a profit of $2.86 per share for the year -LSEG

Up to last close, BSX shares rose 6.4% YTD